Showing 1 - 20 results of 21 for search 'Jason Roszik', query time: 1.52s
Refine Results
-
1
Opportunities for Single-Cell Sequencing Technologies and Data Science by Lisa Maria Mustachio, Jason Roszik
Published 2020-11-01
Article -
2
Single-Cell Sequencing: Current Applications in Precision Onco-Genomics and Cancer Therapeutics by Lisa Maria Mustachio, Jason Roszik
Published 2022-01-01
Article -
3
Targeting iNOS to increase efficacy of immunotherapies by Suhendan Ekmekcioglu, Elizabeth A. Grimm, Jason Roszik
Published 2017-05-01
Article -
4
Targeting <i>KRAS</i> in Cancer: Promising Therapeutic Strategies by Lisa Maria Mustachio, Anca Chelariu-Raicu, Lorant Szekvolgyi, Jason Roszik
Published 2021-03-01
Article -
5
Cancer Genetics and Therapeutic Opportunities in Urologic Practice by Jacob J. Adashek, Alex Leonard, Jason Roszik, Arjun K. Menta, Giannicola Genovese, Vivek Subbiah, Pavlos Msaouel
Published 2020-03-01
Article -
6
-
7
-
8
-
9
Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets by Jason Roszik, Abir Khan, Anthony P. Conley, J. Andrew Livingston, Roman Groisberg, Vinod Ravi, Roberto Carmagnani Pestana, Shiraj Sen, Vivek Subbiah
Published 2019-08-01
Article -
10
The Expression of CD74-Regulated Inflammatory Markers in Stage IV Melanoma: Risk of CNS Metastasis and Patient Survival by Dai Ogata, Jason Roszik, Junna Oba, Sun-Hee Kim, Roland L. Bassett, Lauren E. Haydu, Keiji Tanese, Elizabeth A. Grimm, Suhendan Ekmekcioglu
Published 2020-12-01
Article -
11
Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor Growth by Chandrani Chattopadhyay, Rajat Bhattacharya, Jason Roszik, Fatima S. Khan, Gabrielle A. Wells, Hugo Villanueva, Yong Qin, Rishav Bhattacharya, Sapna P. Patel, Elizabeth A. Grimm
Published 2022-12-01
Article -
12
Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo by Fan Fan, Susmita Ghosh, Reid Powell, Jason Roszik, Yongsun Park, Mary Sobieski, Alexey Sorokin, Clifford Stephan, Scott Kopetz, Lee M. Ellis, Rajat Bhattacharya
Published 2023-01-01
Article -
13
Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo. by Fan Fan, Susmita Ghosh, Reid Powell, Jason Roszik, Yongsun Park, Mary Sobieski, Alexey Sorokin, Clifford Stephan, Scott Kopetz, Lee M Ellis, Rajat Bhattacharya
Published 2023-01-01
Article -
14
Loss of AMPKα2 promotes melanoma tumor growth and brain metastasis by Ping Yuan, Da Teng, Evelyn de Groot, Man Li, Sebastian Trousil, Che-Hung Shen, Jason Roszik, Michael A. Davies, Y.N. Vashisht Gopal, Bin Zheng
Published 2023-06-01
Article -
15
Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma by Yasunari Fukuda, Matias A. Bustos, Sung-Nam Cho, Jason Roszik, Suyeon Ryu, Victor M. Lopez, Jared K. Burks, Jeffrey E. Lee, Elizabeth A. Grimm, Dave S. B. Hoon, Suhendan Ekmekcioglu
Published 2022-02-01
Article -
16
BRAF v600E–mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study by Blessie Elizabeth Nelson, Jason Roszik, Filip Janku, David S. Hong, Shumei Kato, Aung Naing, Sarina Piha-Paul, Siqing Fu, Apostolia Tsimberidou, Maria Cabanillas, Naifa Lamki Busaidy, Milind Javle, Lauren Averett Byers, John V. Heymach, Funda Meric-Bernstam, Vivek Subbiah
Published 2023-02-01
Article -
17
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study by Blessie Elizabeth Nelson, Jason Roszik, Jibran Ahmed, Carmelia Maria Noia Barretto, Mirella Nardo, Erick Campbell, Amber M Johnson, Sarina A. Piha-Paul, Isabella C. Glitza Oliva, Shiao-Pei Weathers, Maria Cabanillas, Milind Javle, Funda Meric-Bernstam, Vivek Subbiah
Published 2024-03-01
Article -
18
Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis by Zibo Chen, Lin Zheng, Yulong Chen, Xiuxia Liu, Masanori Kawakami, Lisa Maria Mustachio, Jason Roszik, Katherine V. Ferry-Galow, Ralph E. Parchment, Xin Liu, Thorkell Andresson, Gerard Duncan, Jonathan M. Kurie, Jaime Rodriguez-Canales, Xi Liu, Ethan Dmitrovsky
Published 2022-12-01
Article -
19
MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma by Anthony P. Conley, Wei-Lien Wang, John A. Livingston, Vinod Ravi, Jen-Wei Tsai, Ali Ali, Davis R. Ingram, Caitlin D. Lowery, Christina L. Roland, Neeta Somaiah, Patrick Hwu, Cassian Yee, Vivek Subbiah, Andrew Futreal, Alexander J. Lazar, Shreyaskumar Patel, Jason Roszik
Published 2019-05-01
Article -
20
Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies by Omar Alhalabi, Roman Groisberg, Ralph Zinner, Andrew W. Hahn, Aung Naing, Shizhen Zhang, Apostolia M. Tsimberidou, Jordi Rodon, Siqing Fu, Timothy A. Yap, David S. Hong, Ming Sun, Yunfang Jiang, Shubham Pant, Amishi Y. Shah, Amado Zurita, Nizar M. Tannir, Raghunandan Vikram, Jason Roszik, Funda Meric-Bernstam, Vivek Subbiah
Published 2023-04-01
Article